CDSCO issues a list of spurious, adulterated, misbranded, or non-standard quality drugs, medical devices and cosmetics for the month of September, 2022

CDSCO issues a list of spurious, adulterated, misbranded, or non-standard quality drugs, medical devices and cosmetics for the month of September, 2022

CDSCO issues a list of spurious, adulterated, misbranded, or non-standard quality drugs, medical devices and cosmetics for the month of September, 2022

by Lexplosion | Oct 21, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

Ministry of Health releases revised National List of Essential Medicines; 34 new drugs added to list and 26 drugs deleted

Ministry of Health releases revised National List of Essential Medicines; 34 new drugs added to list and 26 drugs deleted

by Lexplosion Solution | Sep 19, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

National Pharmaceutical Pricing Authority fixes the retail price for certain formulations; overcharged amount (with interest) to be imposed for non-compliance

National Pharmaceutical Pricing Authority fixes the retail price for certain formulations; overcharged amount (with interest) to be imposed for non-compliance

by Lexplosion Solution | Apr 21, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

Central Government issues Guidelines for Scheme to Strengthen Pharmaceuticals Industry (SPI); aims to strengthen existing infrastructure facilities to improve productivity, quality and sustainability

Central Government issues Guidelines for Scheme to Strengthen Pharmaceuticals Industry (SPI); aims to strengthen existing infrastructure facilities to improve productivity, quality and sustainability

by Lexplosion Solution | Apr 12, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

Central Govt. extends timeline for submission of applications under the ‘PLI Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials / Drug Intermediates and APIs’ till 31st March, 2022

Central Govt. extends timeline for submission of applications under the ‘PLI Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials / Drug Intermediates and APIs’ till 31st March, 2022

by Lexplosion | Mar 25, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

DGCI classifies medical device pertaining to Paediatrics & Neonatology, Obstetrical & Gynaecological and Urology under the provisions of Medical Devices Rules, 2017

DGCI classifies medical device pertaining to Paediatrics & Neonatology, Obstetrical & Gynaecological and Urology under the provisions of Medical Devices Rules, 2017

by Lexplosion Solution | Aug 27, 2021 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

« Older Entries

Next Entries »